|
Jun 30
|
Changes to the Roche Enlarged Corporate Executive Committee
|
|
Jun 27
|
Initiation of commercialization of ProNephro AKI (NGAL) for diagnostic use in the US
|
|
Jun 26
|
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
|
|
Jun 26
|
Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
|
|
Jun 25
|
96% of health care executives are "ready and resourced" to use digital health solutions, yet two-thirds say interoperability is "a tough but manageable challenge," reveals new MIT Technology Review Insights report
|
|
Jun 23
|
Exelixis Surges On Positive Results For Next-Gen Colon Cancer Drug
|
|
Jun 23
|
Roche and Genentech’s Lunsumio-Polivy shows promise in Phase III trial
|
|
Jun 23
|
Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A
|
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
|
Apr 17
|
Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback
|
|
Apr 14
|
Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe
|
|
Apr 14
|
Roche’s Columvi combo gains EC approval for DLBCL
|
|
Apr 14
|
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
|
|
Apr 10
|
Tempest hits funding block for Phase III liver cancer drug-in-waiting
|
|
Apr 10
|
Tempest seeks strategic alternatives as cash runs out for Phase 3 trial
|
|
Apr 9
|
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More
|
|
Apr 9
|
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
|
|
Apr 9
|
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
|
|
Apr 7
|
Sarepta and Roche aim to resume paused Elevidys trials following patient death
|
|
Mar 14
|
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
|